Word

Status

Registered

Status Code

700

Status Date

Tuesday, April 27, 2021

Serial Number

79286383

Registration Number

6331130

Registration Date

Tuesday, April 27, 2021

Mark Type

2000

Filing Date

Wednesday, April 15, 2020

Published for Opposition

Tuesday, February 9, 2021

Trademark Owner History

NEUWAY Pharma GmbH - Original Registrant

Classifications

40 Manufacture of pharmaceutical products, medicinal products, and medicaments from pharmaceutical compositions for others

5 Chemical, biological, biochemical and biotechnological products and preparations for medical, veterinary and pharmaceutical purposes for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions and derivatives thereof; diagnostic preparations for medical and veterinary use; vaccines; healthcare preparations, medicines, medicinal preparations, pharmaceutical preparations and pharmaceutical substances for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation; pharmaceutical preparations and substances, namely, adjuvants, carriers for active ingredients and drug delivery systems comprising protein based capsids or particles for the release of therapeutic or diagnostic agents for medical use in humans or animals; biological implants comprising active ingredients

1 Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions, derivatives, components and lysates thereof; chemical, biological, biochemical and biotechnological chemical products and preparations for laboratory or research use and manufacturing use, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms as well as fragments, fractions, derivatives, components and lysates thereof

42 Scientific research and development for others, in particular in the fields of medicine, pharmacy, diagnostics, chemistry, biology, biochemistry and biotechnology; scientific research and development as well as biotechnological research and development services for others with regard to manufacturing pharmaceutical preparations, implants comprising active ingredients, carriers for active ingredients and drug delivery systems for medical use in humans or animals; development of pharmaceutical preparations, namely, medical products for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, for others

The mark consists of an incomplete hexagon with an incomplete diamond in the center.
Color is not claimed as a feature of the mark.

Trademark Events

Apr 23, 2022

Change Of Name/Address Rec'd From Ib

Aug 29, 2021

Final Decision Transaction Processed By Ib

Aug 5, 2021

Final Disposition Notice Sent To Ib

Aug 5, 2021

Final Disposition Processed

Jul 27, 2021

Final Disposition Notice Created, To Be Sent To Ib

Apr 27, 2021

Registered-Principal Register

Feb 9, 2021

Official Gazette Publication Confirmation E-Mailed

Feb 9, 2021

Published For Opposition

Feb 6, 2021

Notification Processed By Ib

Jan 20, 2021

Notification Of Possible Opposition Sent To Ib

Jan 20, 2021

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jan 20, 2021

Notification Of Notice Of Publication E-Mailed

Jan 4, 2021

Approved For Pub - Principal Register

Jan 4, 2021

Examiner's Amendment Entered

Jan 4, 2021

Notification Of Examiners Amendment E-Mailed

Jan 4, 2021

Examiners Amendment E-Mailed

Jan 4, 2021

Examiners Amendment -Written

Dec 16, 2020

Applicant/Correspondence Changes (Non-Responsive) Entered

Dec 16, 2020

Teas Change Of Correspondence Received

Dec 16, 2020

Teas Change Of Domestic Representatives Address

Dec 16, 2020

Attorney/Dom.Rep.Revoked And/Or Appointed

Dec 16, 2020

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Dec 16, 2020

Teas Change Of Owner Address Received

Sep 5, 2020

Refusal Processed By Ib

Aug 16, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Aug 15, 2020

Refusal Processed By Mpu

Jul 11, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Jul 10, 2020

Non-Final Action Written

Jul 6, 2020

Assigned To Examiner

Jun 12, 2020

Application Filing Receipt Mailed

Jun 8, 2020

New Application Office Supplied Data Entered In Tram

Jun 5, 2020

Limitation From Original Application Entered

May 28, 2020

Sn Assigned For Sect 66a Appl From Ib